Biggest News Aggregation in the World
📰 Alvr News

Page 3 - Alvr News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alvr. Real-time updates on events, politics, business and more.

AlloVir, Inc. (NASDAQ:ALVR) CEO Sells $16,088.75 in Stock

AlloVir, Inc. (NASDAQ:ALVR – Free Report) CEO Diana Brainard sold 5,275 shares of the company’s stock in a transaction on Wednesday, July 5th. The stock was sold at an average price of $3.05, for a total value of $16,088.75. Following the sale, the chief executive officer now owns 915,641 shares of the company’s stock, valued […]
United Kingdom General United Kingdom Diana Brainard Vanguard Group Inc Capital Corp Blackrock Inc

Insider Buying: AlloVir, Inc. (NASDAQ:ALVR) Major Shareholder Purchases $10,990,762.50 in Stock

AlloVir, Inc. (NASDAQ:ALVR – Free Report) major shareholder Gilead Sciences, Inc. acquired 2,930,870 shares of the stock in a transaction dated Tuesday, June 27th. The stock was acquired at an average cost of $3.75 per share, with a total value of $10,990,762.50. Following the completion of the transaction, the insider now owns 16,635,286 shares in […]
Capital Corp Gilead Sciences Inc Blackrock Inc Vanguard Group Inc Allovir Inc Free Report
Source: wkrb13.com

Analyzing AlloVir (NASDAQ:ALVR) and Vitro Diagnostics (OTCMKTS:VODG)

AlloVir (NASDAQ:ALVR – Free Report) and Vitro Diagnostics (OTCMKTS:VODG – Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Earnings and Valuation This table compares AlloVir and Vitro Diagnostics’ top-line […]
United States Allovir Inc Viracyte Inc Vitro Diagnostics Inc Free Report Vitro Diagnostics

AlloVir, Inc. (NASDAQ:ALVR) CAO Brett R. Hagen Sells 5,045 Shares

AlloVir, Inc. (NASDAQ:ALVR – Get Rating) CAO Brett R. Hagen sold 5,045 shares of AlloVir stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $5.64, for a total transaction of $28,453.80. Following the sale, the chief accounting officer now directly owns 129,512 shares in the […]
Brettr Hagen Allovir Inc Sg Americas Securities Allovir Company Profile Ensign Peak Advisors Inc Swiss National Bank

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

AlloVir (NASDAQ:ALVR) Trading Up 22.4%

AlloVir, Inc. (NASDAQ:ALVR – Get Rating) was up 22.4% during mid-day trading on Tuesday . The stock traded as high as $5.99 and last traded at $5.46. Approximately 449,994 shares traded hands during mid-day trading, an increase of 79% from the average daily volume of 250,811 shares. The stock had previously closed at $4.46. Wall […]
Diana Brainard Nisa Investment Advisors Securities Exchange Commission Ensign Peak Advisors Inc Allovir Inc Swiss National Bank

Blueprint Medicines (NASDAQ:BPMC) Stock Price Down 5.9% on Insider Selling

AlloVir, Inc. (NASDAQ:ALVR – Get Rating)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $5.82, but opened at $5.70. AlloVir shares last traded at $5.74, with a volume of 28,602 shares traded. Wall Street Analyst Weigh In Separately, SVB Securities upped their target price on shares […]
Diana Brainard Allovir Inc Ensign Peak Advisors Inc Securities Exchange Commission Nisa Investment Advisors Get Rating

SVB Securities Boosts AlloVir (NASDAQ:ALVR) Price Target to $19.00

AlloVir (NASDAQ:ALVR – Get Rating) had its price objective upped by SVB Securities from $16.00 to $19.00 in a report issued on Wednesday morning, The Fly reports. ALVR has been the subject of a number of other reports. Morgan Stanley decreased their target price on AlloVir from $27.00 to $20.00 and set an overweight rating […]
Diana Brainard Renaissance Technologies Blackrock Inc Allovir Inc Vanguard Group Inc Morgan Stanley
Source: wkrb13.com

AlloVir (NASDAQ:ALVR) Price Target Raised to $19.00 at SVB Securities

AlloVir (NASDAQ:ALVR – Get Rating) had its price objective boosted by research analysts at SVB Securities from $16.00 to $19.00 in a report issued on Wednesday, The Fly reports. SVB Securities’ target price would suggest a potential upside of 420.55% from the company’s current price. Other equities analysts have also recently issued reports about the […]
Diana Brainard Morgan Stanley Squarepoint Ops Allovir Inc Securities Exchange Commission Allovir Company Profile

AlloVir, Inc. (NASDAQ:ALVR) Sees Significant Growth in Short Interest

AlloVir, Inc. (NASDAQ:ALVR – Get Rating) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 6,460,000 shares, an increase of 11.6% from the March 15th total of 5,790,000 shares. Based on an average daily trading volume, of 277,500 shares, the short-interest ratio is […]
Diana Brainard Denali Advisors Nisa Investment Advisors Morgan Stanley Allovir Inc Get Rating
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science